Psyence Biomedical Ltd (PBM)

NASDAQ
Currency in USD
5.2000
+0.7600(+17.12%)
Closed·
After Hours
5.2100+0.0100(+0.1923%)
·
PBM Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Unusual trading volume
Fair Value
Day's Range
4.59005.5538
52 wk Range
2.9218699.1882
Key Statistics
Edit
Prev. Close
4.4217
Open
4.59
Day's Range
4.59-5.5538
52 wk Range
2.9218-699.1882
Volume
165.83K
Average Volume (3m)
51.08K
1-Year Change
-99.13%
Book Value / Share
-44.93
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PBM Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Quickly burning through cash
Show more

Psyence Biomedical Ltd Company Profile

Psyence Biomedical Ltd. engages in the development of botanical psilocybin-based psychedelic medicines. It also evaluates natural psilocybin for the treatment of adjustment disorder in patients with an incurable cancer diagnosis in a palliative care context. The company’s lead product candidate is PEX010, which is in Phase IIb clinical study, a capsule containing naturally sourced psilocybin for treatment of anxiety and depression, including associated ailments, such as post-traumatic stress disorder, stress, grief, and adjustment disorder in the context of palliative care. It has a partnership with iNGENu Pty Ltd to conduct a Phase IIb clinical trial of PEX010 in psilocybin-assisted psychotherapy for the treatment of AjD due to incurable cancer. The company is based in Toronto, Canada. Psyence Biomedical Ltd. operates as a subsidiary of Psyence Group Inc.

Compare PBM to Peers and Sector

Metrics to compare
PBM
Peers
Sector
Relationship
P/E Ratio
−0.1x−2.1x−0.5x
PEG Ratio
0.00−0.030.00
Price/Book
−2.1x1.2x2.6x
Price / LTM Sales
-4.8x2.9x
Upside (Analyst Target)
-397.9%45.8%
Fair Value Upside
Unlock7.5%8.6%Unlock

Earnings

Latest Release
Jan 23, 2025
EPS / Forecast
0.51 / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

FAQ

What Is the Psyence Biomedical (PBM) Stock Price Today?

The Psyence Biomedical stock price today is 5.20

What Stock Exchange Does Psyence Biomedical Trade On?

Psyence Biomedical is listed and trades on the Nasdaq Stock Exchange stock exchange.

What Is the Stock Symbol for Psyence Biomedical?

The stock symbol for Psyence Biomedical is "PBM."

What Is the Psyence Biomedical Market Cap?

As of today, Psyence Biomedical market cap is 2.58M.

What Is Psyence Biomedical's Earnings Per Share (TTM)?

The Psyence Biomedical EPS (TTM) is -612.98.

From a Technical Analysis Perspective, Is PBM a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.